Biologics Safety Testing Market 2017 Industry Demand, Segment, Statistics Report 2023

1
Biologics Safety Testing Market Global Industry
Analysis, Trends, Market Size and Forecasts up to
2023
2
A latest report has been added to the wide
database of Biologics Safety Testing Market
by Infinium Global Research. This report studies
the Biologics Safety Testing Market by
instruments services (instruments, kits
reagents and services), test type (bioburden
tests, endotoxin tests, adventitious agent
detection tests, cell line authentication and
characterization tests, residual host contaminant
detection tests, adventitious agent detection
tests and other test), market status and
outlook of global and major regions, from
manufacturers, and end industries. The objective
of the study is to identify market sizes of
different segments countries in recent years
and to forecast the values for the next six
years. Biologics Safety Testing Market provides
opportunities in micro markets for stakeholders
to invest along with the detailed analysis of
competitive landscape, latest trends, and product
offerings of the major companies in the Biologics
Safety Testing Market. According to report the
global biologics safety testing market is
expected to grow at a CAGR between 12.0 and 12.5
over the forecast period of 2017 - 2023. Kits
Reagents are estimated to account for the
largest share of the market in 2017 By instrument
and service, the biologics safety testing market
is classified into Instruments, Kits Reagents
and Services. The kits reagents segment is
expected to lead the global biologics safety
testing in 2017. Factors driving the growth of
this segment include increasing and continuous
use of kits reagents, rising prevalence of
genetic disorder as well as growing advancements
in the creation of kits reagents. Vaccine
Therapeutics are estimated to command the largest
share of the market during the forecast period On
the basis of application, the biologics safety
testing market is categorized into Vaccine
Therapeutics Development, Tissue and
Tissue-Related Products Testing, Blood and
Blood-Related Products Testing, Stem Cell
Research and Cellular and Gene Therapy. The
vaccine therapeutics segment is estimated to
account for the largest share of the global
biologics safety testing market during the
forecast period. Increasing target diseases,
growing investment in development of new
vaccines and reduced toxicity are the key
factors driving the growth of this application
segment. North America is estimated to command
the largest share of the market Based on region,
the biologics safety testing market is segmented
into North America, Europe, Asia, and the Rest of
the World (RoW). North America is expected to
dominate the biologics safety testing
market in 2017. This is attributed to
factors such as rising
prevalence of chronic diseases in the region,
presence of key market players as well as growing
investment in RD activities by the key
3
company and government. The report profiles
some of the key companies in the biologic
safety testing market including Toxikon
Corporation, Charles River Laboratories
International, Inc., Avance Biosciences Inc.,
Thermo Fisher Scientific Inc., Merck KGaA, Lonza
Group Ltd., Pace Analytical Services Inc.,
Eurofins Scientific Se, Wuxi Apptec, Sartorius
AG, and Cytovance Biologics, Inc. Get Free Sample
Pages of this Report https//www.infiniumglobalr
esearch.com/Reports/MakeSampleRequest/708 Table
of Contents 1. Preface
1.1. 1.2. 1.3.
Report description Research methods Research
approaches

1. Executive Summary
2. Global Biologics Safety Testing Market Overview

3.1. 3.2. 3.2.1. 3.2.2. 3.2.3. 3.3. 3.4.
Introduction Market dynamics Drivers Restraints
Opportunities Porters five forces
analysis Competitive landscape in the Biologics
Safety Testing Market
4. Global Biologics Safety Testing Market
analysis, by Instruments and Services (USD
million) 2017 2023
4.1. 4.2. 4.3.
Instruments Services Kits Reagents
5. Global Biologics Safety Testing Market
analysis, by Test Type (USD million) 2017 2023
5.1.
Bioburden Tests
4
5.2. 5.3. 5.4. 5.5. 5.6. 5.7.
Endotoxin Tests Adventitious Agent Detection
Tests Cell Line Authentication and
Characterization Tests Sterility Tests Residual
Host Contaminant Detection Tests Other Test Types
6. Global Biologics Safety Testing Market
Analysis, by Application (USD million) 2017 2023
6.1. 6.2. 6.3. 6.4. 6.5.
Vaccine Therapeutics Development Tissue and
Tissue-Related Products Testing Cellular and Gene
Therapy Blood and Blood-Related Products Testing
Stem Cell Research
7. Global Biologics Safety Testing Market
Analysis, Regional Analysis (USD Million) 2017
2023
7.1. 7.1.1. 7.1.2. 7.1.3. 7.1.4. 7.2. 7.2.1. 7.2.2
. 7.2.3. 7.2.4. 7.3. 7.3.1. 7.3.2.
North America North America Biologics Safety
Testing Market by Instruments and Services (USD
Million) North America Biologics Safety Testing
Market by Test Type (USD Million) North America
Biologics Safety Testing Market by Application
(USD Million) North America Biologics Safety
Testing Market by country (USD Million)
Europe Europe Biologics Safety Testing Market by
Instruments and Services (USD Million) Europe
Biologics Safety Testing Market by Test Type (USD
Million) Europe Biologics Safety Testing Market
by Application (USD Million) Europe Biologics
Safety Testing Market by country (USD Million)
Asia Pacific Asia Pacific Biologics Safety
Testing Market by Instruments and Services (USD
Million) Asia Pacific Biologics Safety Testing
Market by Test Type (USD Million)
7.3.3.
Asia Pacific Biologics Safety Testing Market by
Application (USD Million)
5
7.3.4. 7.4. 7.4.1. 7.4.2. 7.4.3. 7.4.4.
Asia Pacific Biologics Safety Testing Market by
country (USD Million) Rest of the World (RoW) RoW
Biologics Safety Testing Market by Instruments
and Services (USD Million) RoW Biologics Safety
Testing Market by Test Type (USD Million) RoW
Biologics Safety Testing Market by Application
(USD Million) RoW Biologics Safety Testing Market
by Sub-region (USD Million)
8. Company profiles
8.1. 8.2. 8.3. 8.4. 8.5. 8.6. 8.7. 8.8. 8.9. 8.10.
8.11. 8.12.
Toxikon Corporation Charles River Laboratories
International, Inc. Avance Biosciences
Inc. Thermo Fisher Scientific Inc. Merck
KGaA Lonza Group Ltd. Pace Analytical Services
Inc. Eurofins Scientific Se Wuxi Apptec Sartorius
AG Cytovance Biologics, Inc. Source Bioscience
Click the Below View Full Report-
https//www.infiniumglobalresearch.com/healthcare_
medical_devices/global_biologics_safety_testing_ma
rket